On March 18, 2024, Gilead Sciences, Inc announced that it has received a shareholder proposal from Jing Zhao requesting the Company to reform the board structure to include one member of board of directors from the Company?s non-management employees. In addition, the Company urged the shareholders to vote against the shareholder proposal at its annual general meeting of shareholders scheduled to be held on May 8, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.92 USD | -0.82% | -0.43% | -19.86% |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
05-02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.86% | 81.63B | |
+32.95% | 700B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B | |
-1.81% | 157B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences Receives a Shareholder Proposal from Jing Zhao